Electromed Inc Q4 Results: Earnings date set for August 25
Electromed, Inc. will report its fiscal 2026 fourth-quarter financial results on August 25, 2026. The earnings call is scheduled for 5:00 p.m. Eastern Time. Investors can access live webcasts and replays via the company's Investor Relations page.
*this image is generated using AI for illustrative purposes only.
Electromed, Inc., a provider of innovative airway clearance technologies, will issue its financial results press release for the fiscal 2026 fourth quarter ended June 30, 2026, on Tuesday, August 25, 2026, after the close of the stock market. This announcement sets the timeline for investors to review the company's latest operational and financial performance. Management will host a conference call on the same day at 5:00 p.m. Eastern Time to discuss the results.
Earnings Call Details
Interested parties may participate in the call by dialing (877) 407-3982 (Toll Free) or (201) 493-6780. A live webcast of the call will be accessible in the Investor Relations section of Electromed’s website.
| Detail | Information |
|---|---|
| Date | August 25, 2026 |
| Time | 5:00 p.m. Eastern Time |
| Dial-in (Toll Free) | (877) 407-3982 |
| Dial-in (Local) | (201) 493-6780 |
For those who cannot listen to the live broadcast, a replay will be available by dialing (844) 512-2921 (Toll Free) or (412) 317-6671 and referencing Access ID 13761827. Additionally, a replay of the webcast will be available in the Investor Relations section of Electromed’s website.
About Electromed, Inc.
Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992.
Brad Nagel, Chief Financial Officer, serves as the primary contact for investor inquiries at (952) 758-9299 or investorrelations@electromed.com . Mike Cavanaugh of ICR Healthcare is also available for investor relations support at (617) 877-9641.
How might Electromed's Q4 2026 revenue growth compare to its full-year guidance, and what does this indicate for fiscal 2027 projections?
Will management provide updated commentary on the adoption rate of the SmartVest system in emerging international markets during the earnings call?
Are there any anticipated changes to the company's R&D pipeline or product roadmap for airway clearance technologies based on the latest financial performance?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
